  In the research, we developed a computer vision solution to support
diagnostic radiology in differentiating between COVID-19 pneumonia, influenza
virus pneumonia, and normal biomarkers. The chest radiograph appearance of
COVID-19 pneumonia is thought to be nonspecific, having presented a challenge
to identify an optimal architecture of a convolutional neural network (CNN)
that would classify with a high sensitivity among the pulmonary inflammation
features of COVID-19 and non-COVID-19 types of pneumonia. Rahman (2021) states
that COVID-19 radiography images observe unavailability and quality issues
impacting the diagnostic process and affecting the accuracy of the deep
learning detection models. A significant scarcity of COVID-19 radiography
images introduced an imbalance in data motivating us to use over-sampling
techniques. In the study, we include an extensive set of X-ray imaging of human
lungs (CXR) with COVID-19 pneumonia, influenza virus pneumonia, and normal
biomarkers to achieve an extensible and accurate CNN model. In the
experimentation phase of the research, we evaluated a variety of convolutional
network architectures, selecting a sequential convolutional network with two
traditional convolutional layers and two pooling layers with maximum function.
In its classification performance, the best performing model demonstrated a
validation accuracy of 93% and an F1 score of 0.95. We chose the Azure Machine
Learning service to perform network experimentation and solution deployment.
The auto-scaling compute clusters offered a significant time reduction in
network training. We would like to see scientists across fields of artificial
intelligence and human biology collaborating and expanding on the proposed
solution to provide rapid and comprehensive diagnostics, effectively mitigating
the spread of the virus
